The Symptoms-Varices-Pathophysiology classification of pelvic venous disorders: A report of the American Vein & Lymphatic Society International Working Group on Pelvic Venous Disorders.
The overall tone reflects cautious recognition of the disease as real, with comments that reference the new classification system and its potential to improve diagnosis and patient care, using words like 'needed' and 'work,' which imply ongoing development and moderate engagement.
AgreementModerate agreement
Some discussions acknowledge the legitimacy of pelvic venous disorders as a real condition, highlighting varying perceptions of its recognition and coverage.
InterestModerate interest
Interest is moderate, with participants showing curiosity about classification systems and clinical implications but not delving deeply into controversial debates.
EngagementModerate engagement
Posts reference specific studies like the SVP classification and emphasize the need for further work, indicating active but not highly detailed engagement.
ImpactModerate impact
The discussions suggest a recognition of the importance of improved classification for diagnosis and insurance coverage, but the overall impact remains developmental rather than transformational.
Abstract in brief
The American Vein and Lymphatic Society developed the SVP classification system to better categorize pelvic venous disorders (PeVD), addressing the limitations of previous, often misleading terminology like pelvic congestion syndrome.
The SVP system uses three main domains—Symptoms (S), Varices (V), and Pathophysiology (P)—which further include details about anatomy (A), hemodynamics (H), and causes (E), providing a comprehensive way to describe individual patient conditions.
This new classification complements existing tools like the CEAP system, aiming to improve diagnosis, guide treatment decisions, and create more uniform patient groups for research and clinical trials.]
To recap: put this out yesterday. Many agreed this is a real disease for women but not covered by many payors. In a way they are correct. Uneven data out there re: PRO and QoL. We need to do some work. See SVP classification in JVS V&L: https://t.co/I6rSrzL8JD by Meissner et al. https://t.co/xyNonSQJOa
Oct 19, 2021 · 18 likes · 4 shares · 766 followersView post →
JF
Janice Newsome MD FSIR
@angiowoman · X
RT @DrSteveElias: To recap: put this out yesterday. Many agreed this is a real disease for women but not covered by many payors. In a way t…
Oct 20, 2021 · 4 shares · 6,302 followersView post →
OD
Omar Chohan, DO
@drochohan · X
RT @DrSteveElias: To recap: put this out yesterday. Many agreed this is a real disease for women but not covered by many payors. In a way t…
Oct 19, 2021 · 4 shares · 4,849 followersView post →
K
keys
@justin_Kies1 · X
RT @DrSteveElias: To recap: put this out yesterday. Many agreed this is a real disease for women but not covered by many payors. In a way t…
SymptomsVaricesPathophysiology is a detailed overview of the SVP classification system for pelvic venous disorders, developed by the American Vein and Lymphatic Society. It enhances diagnosis, treatment guidance, and…
The American Vein Lymphatic Society developed the SVP classification system to better categorize pelvic venous disorders, addressing limitations of previous terminology like pelvic congestion syndrome. The system…
RT @DrSteveElias: To recap: put this out yesterday. Many agreed this is a real disease for women but not covered by many payors. In a way t…
Oct 19, 2021 · 4 shares · 4,849 followersView post →
DE
Dr. Steve Elias
@DrSteveElias · X
To recap: put this out yesterday. Many agreed this is a real disease for women but not covered by many payors. In a way they are correct. Uneven data out there re: PRO and QoL. We need to do some work. See SVP classification in JVS V&L: https://t.co/I6rSrzL8JD by Meissner et al. https://t.co/xyNonSQJOa
Oct 19, 2021 · 18 likes · 4 shares · 766 followersView post →
N
Venous Leg Disease | PDF
News
J Vase Surg Venous Lymphat Disord 2021; 9: pp. 568-584, View In Article Cross Ref (httpv/dx.dol.org/10.1016)jvsv-2020.12.084) $1. Bora A,, Aveu S., Arslan H ...
DE
JF
OD
K
NC